Literature DB >> 15607387

The relationship between HAART use and employment for HIV-positive individuals: an empirical analysis and policy outlook.

Stephanie Lazarus Bernell1, Judith Ann Shinogle.   

Abstract

OBJECTIVE: This study jointly analyzes the determinants of the use of highly active antiretroviral therapy (HAART) along with the determinants of employment status for human immunodeficiency virus (HIV)-positive individuals.
METHODS: Data from the HIV Cost and Services Utilization Study (HCSUS) were analyzed using a bivariate probit model. HSCUS collected data on 2864 individuals in 180 clinics, hospitals and private practices in 28 urban areas and 24 clusters of rural counties in the United States. We used data from the baseline interview to categorize individuals as employed or unemployed and for the determination of HAART use.
RESULTS: The empirical results suggest that individuals taking HAART have an increased likelihood of working and that individuals with private health insurance are more likely to use HAART compared to individuals with public health insurance coverage or no coverage.
CONCLUSIONS: Due to the fact that employment of HIV-positive is directly related to HAART use, policymakers need to look to the private health insurance industry and public program to increase access to HAART. Suggested models for consideration are mandating insurance benefits and ADAP expansion.

Entities:  

Mesh:

Year:  2005        PMID: 15607387     DOI: 10.1016/j.healthpol.2004.08.012

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  9 in total

1.  Highly active antiretroviral therapy and employment status in accra, ghana.

Authors:  Iw Howley; M Lartey; J T Machan; E A Talbot; A Obo-Akwa; T P Flanigan; A Kwara
Journal:  Ghana Med J       Date:  2010-12

2.  Exploring Social Determinants of Health as Predictors of Mortality During 2012-2016, Among Black Women with Diagnosed HIV Infection Attributed to Heterosexual Contact, United States.

Authors:  Lakeshia Watson; Zanetta Gant; Xiaohong Hu; Anna Satcher Johnson
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-12

3.  Determinants of health care costs of HIV-positive patients in the Canary Islands, Spain.

Authors:  Juan Oliva-Moreno; Julio López-Bastida; Pedro Serrano-Aguilar; Lilisbeth Perestelo-Pérez
Journal:  Eur J Health Econ       Date:  2010-01-05

4.  An instrumental variables evaluation of the effect of antidepressant use on employment among HIV-infected women using antiretroviral therapy in the United States: 1996-2004.

Authors:  Omar Galárraga; David S Salkever; Judith A Cook; Stephen J Gange
Journal:  Health Econ       Date:  2010-02       Impact factor: 3.046

5.  The employment situation of people living with HIV: a closer look at the effects of the 2008 economic crisis.

Authors:  Beatriz Rodríguez-Sánchez; Luz María Peña-Longobardo; Juan Oliva-Moreno
Journal:  Eur J Health Econ       Date:  2021-09-03

6.  Economic impact of HIV/AIDS: a systematic review in five European countries.

Authors:  Marta Trapero-Bertran; Juan Oliva-Moreno
Journal:  Health Econ Rev       Date:  2014-09-16

7.  What determines employment quality among people living with HIV: An empirical study in China.

Authors:  Yunjiang Yu; Zhi Chen; Shenglan Huang; Zhicheng Chen; Kailin Zhang
Journal:  PLoS One       Date:  2020-12-01       Impact factor: 3.240

8.  The economic costs and health-related quality of life of people with HIV/AIDS in the Canary Islands, Spain.

Authors:  Julio Lopez-Bastida; Juan Oliva-Moreno; Lilisbeth Perestelo-Perez; Pedro Serrano-Aguilar
Journal:  BMC Health Serv Res       Date:  2009-03-30       Impact factor: 2.655

9.  The longitudinal impact of employment, retirement and disability status on depressive symptoms among men living with HIV in the Multicenter AIDS Cohort Study.

Authors:  Deanna Ware; Sergio Rueda; Michael Plankey; Pamela Surkan; Chukwuemeka N Okafor; Linda Teplin; M Reuel Friedman
Journal:  PLoS One       Date:  2020-10-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.